http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0012543-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
filingDate 1999-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd1159e60149158b4a141933d863cbe8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d97bf49125846fa3442d860589af591
publicationDate 2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0012543-A3
titleOfInvention Crystalline farnesyl protein transferase compositions and methods for use
abstract The present invention relates to crystalline compositions comprising farnesyl protein transferase-like polypeptides in complex with substrates and inhibitors. Also disclosed are crystallization conditions for these compositions and their use for structural determination of FPT:FPP/FPP analog:peptide/inhibitor complexes.
priorityDate 1998-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525479-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393350

Total number of triples: 15.